Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration.
D058186:Acute Kidney Injury / Q000378:metabolism / Q000628:therapy; D000328:Adult; D000900:Anti-Bacterial Agents / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D019540:Area Under Curve; D016638:Critical Illness; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D005260:Female; D016231:Fluorescence Polarization Immunoassay; D006207:Half-Life; D017583:Hemodiafiltration / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D016014:Linear Models; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D008970:Molecular Weight; D017334:Teicoplanin / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D013997:Time Factors; D014018:Tissue Distribution
D000900:Anti-Bacterial Agents; D017334:Teicoplanin